Hospira Stock Seesaws After Mixed Q4 Report, GuidanceShares of Hospira (HSP) hit a six-month high early Wednesday, but then plunged and was down more than 8% in afternoon trading, after the company issued a mixed earnings report and continued its struggles with the FDA. The company, which sells a mixture of generic drugs and drug-delivery devices, narrowly beat analysts' Q4 expectations with profit of 55 cents a share and sales of $1.1 billion, both up 8% from the year-earlier quarter. However, its
Source:
Hospira Stock Seesaws After Mixed Q4 Report, GuidanceLinkback:
https://tubagbohol.mikeligalig.com/index.php?topic=68725.0
Topic: Technology: Hospira Stock Seesaws After Mixed Q4 Report, Guidance (Read 408 times)